Ultima-Prostamax 20mg – 1 vial x 20mg – UltimaPeptides USA

The Prostamax peptide is a synthetic bioregulatory peptide complex developed by Professor Vladimir Khavinson at the Institute of Bioregulation and Gerontology in Saint Petersburg. Prostamax targets prostate tissue, acting as a prostate bioregulator that modulates gene expression in prostate epithelial cells, stromal cells, and supporting glandular tissue. It belongs to the class of Khavinson bioregulatory peptides—short regulatory peptides that exhibit tissue-specific modulation of gene expression at physiological concentrations—and has been studied in preclinical models of age-related prostate changes, prostate tissue repair, chronic prostatic inflammation, and aging of the male reproductive system.